According to statistics, the population of children in China is 230 million, accounting for the total population of the country. affected by the two-child policy in the future, the population of children will show an increasing trend, and the market for children's drug use has great potential. However, the domestic market share of children's medicine and medical care is occupied by a few foreign-funded enterprises, such as Wyeth, Roche, Squibb and so on. Developed countries have corresponding policy support for the development of special drugs for children and clinical trials, and give preferential measures to pharmaceutical enterprises in terms of taxation, patents, market and research subsidies.
passage?
The domestic market for children's medication and medical care is basically monopolized by foreign-funded enterprises